Web notes  

June 2020
FUNDING OPPORTUNITIES- Back

Boost and Propel Clinical Research Awards

APPLICATION DEADLINE: Monday, June 15th, 11:59 PM

We are currently accepting applications for our Boost and Propel awards. Boost and Propel are clinical research grants that award Clinical Research Unit (CRU) services, including research space, overnight beds, phlebotomy, specialized research nursing, and CRU-based imaging (i.e. DXA, CV core) to investigators, based on scientific merit. Grants are for one year with possible renewal based on study progress and achieving pre-determined milestones.

BOOST awards are for junior investigators, first-time R01 awardees, K awardees, and KL2 scholars to generate pilot data for a larger grant submission or to supplement research funds for the K project.

PROPEL awards are intended for established investigators who are performing early stage clinical trials, deep phenotyping studies, or studies that address Maryland health priorities and can augment resources of a funded project or provide resources for small pilot and feasibility studies.

All investigators must submit an application to a Johns Hopkins Institutional Review Board (IRB) before beginning the award application.

The application deadline is Monday, June 15, 2020 by 11:59 pm. Any Johns Hopkins University faculty member interested in funding for a new or ongoing clinical research project is eligible to apply.

Please review the full Request for Applications to see the complete list of required supporting documents.

For more information, please contact Shernice Madison at smadison@jhu.edu or crus@jhmi.edu.

Read more:

Boost and Propel Award Information

Frequently Asked Questions

Request for Applications


COVID-19 Funding Opportunities

The Office of the Vice Provost for Research (VPR) has compiled a list of funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.


Lustgarten Foundation Therapeutics Focused Research Program

Internal Application Deadline: June 9, 2020

Letter of Intent Deadline: June 30, 2020

The Lustgarten Foundation seeks outstanding researchers with innovative research projects that have the most potential to impact our understanding of, and management of, these processes in pancreatic cancer. The intent of this program is to support pancreatic cancer research critical to advancing our understanding of pancreatic cancer initiation, progression and the development of new therapies in four areas of focus: Desmoplastic Stroma, Chronic inflammation, Metabolic Dysregulation, Early Metastasis.

Eligibility & Requirements:

  • Applicants must hold an academic appointment rank of Assistant Professor or higher.
  • Must be engaged in significant pancreatic cancer and/or relevant focus area research as a Principal Investigator.
  • Must devote at least 10% effort as Principal Investigator of proposed project; must also have staff members in laboratory who will dedicate 100% effort to the proposal.
  • Must have outstanding research accomplishments as evidenced by publications and peer-reviewed funding.

Internal Nomination Process:
Interested applicants should complete their application at the following link: https://jhu.infoready4.com/#competitionDetail/1815772.

Requirements are listed below.

  1. Proposal (please use template found at link above)
  2. Curriculum Vitae of investigator, including current external research support and publications
  3. Letter of Support from the Department Chair/Director

Questions? Comments? Email the Office of Foundation Relations at FoundationRelations@jhu.edu.


Mallinckrodt Foundation Grants

Internal Application Deadline: June 11, 2020

Full Application Deadline: August 1, 2020

Opportunity Summary:
The Edward Mallinckrodt, Jr. Foundation is a private foundation that funds basic biomedical research to support early stage investigators engaged in biomedical research that has the potential to significantly advance the understanding, diagnosis, or treatment of disease. The Foundation directs approximately 30% of its annual grant funding to Washington University.

Eligibility & Requirements:
Applicants must hold M.D. and/or Ph.D. degrees and should be in the first to fourth year of their tenure track faculty position. " Investigator cannot have current R01 funding.

Internal Application Process:
Interested applicants should complete their application at the following link: https://jhu.infoready4.com/#competitionDetail/1813575.

Requirements are listed below.

  1. Proposal (maximum of two pages of text only, single spaced: 12-pt font and one-inch margins) Note: figures, tables, and other reference material may be included in addition to the 2 pg. text limit
  2. NIH-format biosketch of investigator, including current external research support and publications (5-page limit)
  3. Budget (two pages maximum)

Questions? Comments? Email the Office of Foundation Relations at FoundationRelations@jhu.edu.


Michael J. Fox Foundation (MJFF) Challenge

No application deadline

The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.

The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson's disease (PD) field. The accumulation of aggregated alpha-synuclein is a pathological hallmark of PD and a priority target for drug development given its hypothesized contribution to neurodegeneration. In vivo imaging of alpha-synuclein pathology could be useful as a biomarker of the presence of disease and disease progression and as a pharmacodynamic tool for drug development. With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.

Contestants: Anyone is eligible for the prize who agrees to all contest rules. Contestants may be MJFF funded or not and can be from either academia or industry.

Contest rules:

  1. Contestants must apply for the prize with pre-clinical and clinical data supporting the broad use of their alpha-synuclein radiotracer. Judges may ask for additional data, including but not limited to raw imaging data.
  2. NOTE: All contestants must agree to make the winning radiotracer available for use by The Michael J. Fox Foundation and MJFF awardees through a nonexclusive license or other MJFF-approved mechanism.

Criteria for winning: The winning contestant must demonstrate that the radiotracer binds with relatively high selectivity to alpha-synuclein according to pre-specified criteria and must demonstrate proof-of-concept in human subjects, including people with Parkinson's disease and/or another synucleinopathy. See below for more details on submission requirements.

Timeline: There is no deadline for submissions. The $2 million award will be issued to the first contestant who submits compelling evidence of a viable selective tracer and agrees to its widespread use. If no award is given by mid-2018, The Michael J. Fox Foundation will evaluate the state of the field and utility of such a prize.


Return to top of Funding Opportunities

 
   
June 2020 articles:
Essential Information for Human Subjects Research Teams Related to COVID-19
Coronavirus Research Billing Notices and FAQ
Research Billing Buzz eNewsletter
Managing Investigational Product Returns from Research Participants
Update to Organization Policy on Registration of Clinical Trials
Changes in HSR Recertification
Update on Insurance and Research Participant Financial Responsibility Information Sheet: Signature No Longer Required
Change in JHM IRB Review Fees for Commercially-Funded Studies
Data and Safety Monitoring Board Training Manual Now Available
Good Clinical Practice (GCP) Fundamentals: Understanding and Applying GCP to Human Subject Research
Fee Schedule Adjustment for Hospital Services Charged to Clinical Trial Budgets
Changes to NIH-funded Human Subjects Research
Free Resources for Longitudinal Clinical Research Studies
JHM IRB Reliance Requests
Sharing Partnership for Innovative Research in Translation
Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins Clinical Research Network
 
Visit Animal Care and Use Committee Website
Current Classes
"Interinstitutional Assurance" Agreement
Health, Safety, and Environment (HSE) presents: Safety in Research Updates
COVID-19 Funding Opportunities
National Science Foundation (NSF) Partnerships for Innovation (PFI) Program
1907 Trailblazer Award
Michael J. Fox Foundation (MJFF) Challenge
Updated Guidance from NIH on COVID-19 Flexibilities for Applicants and Recipients
COVID-19 and Research Updates
Townhall Thursdays - Providing a Pulse on What's Happening in Research at JHU
New System to Request Outgoing Subawards
Point of Contact for NIH Loan Repayment Program
JHU SOM Update on NIH Policy on Foreign Involvement
Disclosure of Payments from Foreign Educational Institutions and Government Agencies
Institutional Letter of Support Required for Institutional Training Grant Applications
Notice to the Johns Hopkins Community Regarding the National Science Foundation Grant Reporting Requirement for Harassment Findings and Actions
Prohibited Mention of Prior Review for New Replacement Applications
NIH Policy on Foreign Component Involvement
NIH Policy: Foreign Components Added to a Grant to a Domestic or Foreign Organization
Why Project Outcomes Matter in your Interim and Final Research Performance Progress Report (RPPR)
NIH Matchmaker, A Tool For Finding Similar NIH Projects
NIH Video Tutorials on How to Apply for Grants

This Month's Departmental Listings

Upcoming Deadlines for June and July

Temporary Closures and Updates at the Genetics Research Core Facilities
       

 

JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 

 

                                                                                                                                                           The Web Center